Diagnosing Psoriatic Arthritis for the Dermatologist Diagnosing Psoriatic Arthritis for the Dermatologist
Drs Alice Gottlieb and Joseph Merola present a masterclass for dermatologists in how to recognize psoriatic arthritis in their patients, thereby enabling prompt intervention.Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2024 Category: Consumer Health News Tags: Dermatology Commentary Source Type: news
Guselkumab Provides Long-Term Relief From PsA Symptoms Guselkumab Provides Long-Term Relief From PsA Symptoms
Guselkumab improved joint swelling, spinal pain, skin symptoms, and overall disease activity in a substantial number of patients with psoriatic arthritis through 2 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 17, 2024 Category: Consumer Health News Tags: Rheumatology Clinical Summary Source Type: news
Europe's Quest for Earlier Diagnosis of Psoriatic Arthritis Europe's Quest for Earlier Diagnosis of Psoriatic Arthritis
The HIPPOCRATES consortium aims to help predict those who will develop the condition, diagnose it earlier, and one day even prevent it.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 25, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Psoriatic Arthritis: Updated Guideline Clarifies Treatment Sequence
(MedPage Today) -- Clinicians looking for a fresh and authoritative guide to drug treatment for psoriatic arthritis (PsA) can thank the European Alliance of Associations for Rheumatology (EULAR), which just published an updated recommendation document... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2024 Category: Dermatology Source Type: news
Early Diagnosis Improves Clinical Outcomes in PsA Early Diagnosis Improves Clinical Outcomes in PsA
Psoriatic arthritis diagnosis by a rheumatologist within a year of symptom onset improved long-term clinical outcomes, a study showed.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 18, 2024 Category: Rheumatology Tags: Rheumatology Source Type: news
Why Is MoonLake Immunotherapeutics Stock Trading Higher Today?
On Sunday, MoonLake Immunotherapeutics MLTX announced that continued treatment with Nanobody sonelokimab led to significant improvements across all key outcomes at 24-week data from the ARGO trial in psoriatic arthritis (PsA). The 207-patient ARGO trial demonstrated that the primary endpoint, the…#pasi #abbvieincs #abbvhumira #acr50pasi100 #acr #mda #tnf #moonlake (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
Resistance Training Beneficial in PsA Regardless of Format Resistance Training Beneficial in PsA Regardless of Format
Two types of strength training were associated with similar improvements in function and disease activity in a randomized trial of patients with psoriatic arthritis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news
Using Baseline Markers to Predict Response in Psoriatic Arthritis
(MedPage Today) -- In this final of four exclusive episodes, MedPage Today brought together three expert leaders in the field, all from the Cleveland Clinic -- moderator M. Elaine Husni, MD, MPH, is joined by Leonard Calabrese, DO, and Anthony... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 13, 2023 Category: Dermatology Source Type: news
Improvements With Guselkumab in Psoriatic Arthritis Seen Across All MDA Domains
(MedPage Today) -- At the American College of Rheumatology annual meeting, results from the phase IIIb COSMOS trial were presented that examined the association between patient- and physician-reported domains and minimal disease activity (MDA... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 6, 2023 Category: Rheumatology Source Type: news
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
(MedPage Today) -- Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and joint pain scores when treated with deucravacitinib... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 6, 2023 Category: Dermatology Source Type: news
Key Data on Psoriatic Arthritis From ACR 2023 Key Data on Psoriatic Arthritis From ACR 2023
Key data on psoriatic arthritis from ACR 2023 include treatment studies examining izokibep, apremilast, and TAK-279, as well as analysis of treatment response and difficult-to-treat cases.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2023 Category: Consumer Health News Tags: Rheumatology ReCAP Source Type: news
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
(MedPage Today) -- Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and joint pain scores when treated with deucravacitinib... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 5, 2023 Category: Dermatology Source Type: news
PsA Raises Mortality Risk, but Unevenly
(MedPage Today) -- Swedes with psoriatic arthritis (PsA) tended to die earlier than other people, a national case-control study indicated, but the risk varied considerably among different subgroups.
Overall all-cause mortality was 11% higher for... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 4, 2023 Category: Dermatology Source Type: news
New Data on Bimekizumab in Psoriatic Arthritis
(MedPage Today) -- At the American College of Rheumatology annual meeting, new data was presented on the long-term safety and efficacy of bimekizumab (Bimzelx), a dual interleukin (IL)-17A/F inhibitor, in active psoriatic arthritis.
In this second... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 30, 2023 Category: Dermatology Source Type: news
Picture quiz: Toenail presentations
The Nursing in Practice ‘picture quizzes’ aim to test your knowledge through photo presentations of symptoms. Work your way through them to understand the key clinical problems faced by patients, and how to correctly identify them. Press ‘start’ below to begin the quiz.
A 45-year-old woman is concerned about this black line that has appeared under her big toenail. Can you reassure her about the cause?
Fungal nail infection
Melanoma
Subungual haematoma
Ingrowing toenail
A 23-year-old woman wants to know what you are going to do about her ‘manky toenail’ as it is summer and she feels she ...
Source: Nursing in Practice - November 23, 2023 Category: Nursing Authors: Mollie Fraser-Andrews Tags: Dermatology Quiz toenail Source Type: news
